Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells

Summary

This study is for subjects with a type of skin cancer called melanoma. The main purpose of this study is to examine the safety of the study drug (Poly-ICLC) in patients with your disease. The study team would like to know about any side effects a patient may have when given the study drug. Another goal of the study is to determine if combining dendritic cells and the study drug can be possibly used as a vaccine for your disease.

Timeline

Start

2012-10

Primary completion

2013-07

Completion

2013-11

Drugs

Indications